News
Trump on US tariff deal with India
Digest more
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
Pfizer‘s better-than-expected earnings report wasn’t enough to blow away the gloom that has settled over the stock, but shares rose on the CEO’s optimism that anticipated drug tariff’s won ...
Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback